Latest News about JNJ
Recent news which mentions JNJ
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
August 13, 2024
From Benzinga
J&J Moves Closer to Resolving Baby Powder Lawsuits, 75% of Plaintiffs Support $6.5B Settlement
August 13, 2024
From Benzinga
3 Blue-Chip Stocks to Buy on the Dip: August 2024
August 13, 2024
From InvestorPlace
Medicare Costs For Johnson & Johnson's Psoriasis Drug Stelara Double When Obtained at Pharmacies
August 12, 2024
From Benzinga
2 Healthcare Stocks to Buy Hand Over Fist in August
August 09, 2024
From Motley Fool
3 High-Yield Dividend Stocks to Buy and Hold Forever
August 09, 2024
From Motley Fool
Nasdaq Sell-Off: 5 Unstoppable Stocks to Buy That Can Protect Your Principal and Grow Your Wealth in an Unpredictable Market
August 09, 2024
From Motley Fool
From InvestorPlace
3 Dividend Growth Stocks to Buy Hand Over Fist in August
August 07, 2024
From Motley Fool
3 Dividend Growth Stocks to Accumulate on Dips: August Edition
August 06, 2024
From InvestorPlace
From Motley Fool
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
August 03, 2024
From Motley Fool
Looking At Johnson & Johnson's Recent Unusual Options Activity
August 02, 2024
Tickers
JNJ
From Benzinga
From Motley Fool
Comparative Study: Johnson & Johnson And Industry Competitors In Pharmaceuticals Industry
August 01, 2024
From Benzinga
From InvestorPlace
7 Leading MedTech Stocks for Next-Gen Health Solutions
July 31, 2024
From InvestorPlace
From InvestorPlace
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
July 30, 2024
From Benzinga
Q3’s Rising Stars: 3 Dow Stocks for Your Must-Watch List
July 30, 2024
From InvestorPlace
7 Long-Term Stocks to Buy on the Dip: July 2024
July 27, 2024
From InvestorPlace
Tickers
JNJ
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
July 26, 2024
From Benzinga
From InvestorPlace
From InvestorPlace
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
July 24, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.